We are live on
!
Find out more
T
TOBAM Portfolio holdings
AUM
$384M
1-Year Est. Return
10.32%
This Fund
S&P 500
This Quarter
Est. Return
+7.64%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$2.5B
AUM Growth
+$144M
(+6.1%)
Cap. Flow
+$16.9M
Cap. Flow
% of AUM
0.68%
Top 10 Holdings %
Top 10 Hldgs %
23.95%
Holding
453
New
26
Increased
85
Reduced
124
Closed
20
Top Buys
| 1 |
Eli Lilly
LLY
|
+$23M |
| 2 |
Novavax
NVAX
|
+$18.4M |
| 3 |
iQIYI
IQ
|
+$17.4M |
| 4 |
Cboe Global Markets
CBOE
|
+$17M |
| 5 |
Netflix
NFLX
|
+$16.8M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
+$27.7M |
| 2 |
Roku
ROKU
|
+$20.6M |
| 3 |
Simon Property Group
SPG
|
+$16.5M |
| 4 |
NIO
NIO
|
+$15.7M |
| 5 |
Moderna
MRNA
|
+$13.5M |
Sector Composition
| 1 | Consumer Staples | 21.66% |
| 2 | Healthcare | 21% |
| 3 | Consumer Discretionary | 11.38% |
| 4 | Communication Services | 9.41% |
| 5 | Materials | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
PACCAR
PCAR
$66.4B
| $107K | ﹤0.01% |
1,791
| – | – |
|
252
HP
HPQ
$22.7B
| $106K | ﹤0.01% |
3,496
-1,392
| -28% | -$44.5K |
|
253
D.R. Horton
DHI
$42.4B
| $105K | ﹤0.01% |
1,162
| – | – |
|
254
Berkshire Hathaway Class B
BRK.B
$1.06T
| $104K | ﹤0.01% |
376
+192
| +104% | +$53.7K |
|
255
Elanco Animal Health
ELAN
$12.9B
| $102K | ﹤0.01% |
2,930
+960
| +49% | +$31.7K |
|
256
Eversource Energy
ES
$28.1B
| $102K | ﹤0.01% |
1,265
| – | – |
|
257
Fastenal
FAST
$52.2B
| $101K | ﹤0.01% |
3,884
| – | – |
|
258
Equifax
EFX
$21.1B
| $99K | ﹤0.01% |
414
| – | – |
|
259
CBRE Group
CBRE
$41.3B
| $98K | ﹤0.01% |
1,148
| – | – |
|
260
Equity Residential
EQR
$25.9B
| $97K | ﹤0.01% |
1,255
| – | – |
|
261
American Water Works
AWK
$26.4B
| $96K | ﹤0.01% |
620
| – | – |
|
262
Nucor
NUE
$53.9B
| $96K | ﹤0.01% |
+1,001
| New | +$93.6K |
|
263
Aflac
AFL
$63.5B
| $94K | ﹤0.01% |
1,756
-748
| -30% | -$40.8K |
|
264
Delta Air Lines
DAL
$55.3B
| $94K | ﹤0.01% |
2,177
-1,389
| -39% | -$64.3K |
|
265
State Street
STT
$50.5B
| $94K | ﹤0.01% |
1,139
| – | – |
|
266
FIVE9
FIVN
$1.96B
| $92K | ﹤0.01% |
500
+300
| +150% | +$51.7K |
|
267
Occidental Petroleum
OXY
$54.6B
| $92K | ﹤0.01% |
2,942
-108,092
| -97% | -$2.9M |
|
268
Arthur J. Gallagher & Co
AJG
$65.2B
| $91K | ﹤0.01% |
649
| – | – |
|
269
Old Dominion Freight Line
ODFL
$48.6B
| $91K | ﹤0.01% |
718
| – | – |
|
|
ZNGA
270
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $91K | ﹤0.01% |
8,587
+4,849
| +130% | +$51.1K |
|
271
Ball Corp
BALL
$16.7B
| $90K | ﹤0.01% |
1,111
| – | – |
|
272
Labcorp
LH
$23.2B
| $90K | ﹤0.01% |
+381
| New | +$86.8K |
|
273
VF Corp
VFC
$6.66B
| $90K | ﹤0.01% |
1,100
| – | – |
|
274
West Pharmaceutical
WST
$25.3B
| $90K | ﹤0.01% |
251
| – | – |
|
275
Hershey
HSY
$34.8B
| $88K | ﹤0.01% |
503
| – | – |
|
Similar funds
PCM
DFA
BAMG
DR
GCP
DC
GA
VI
TOBAM's Q2 2021 Portfolio in Review
As of Q2 2021, TOBAM held 453 positions worth $2.5B, up 6.1% from $2.35B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
TOBAM's Q2 2021 filing shows 26 new, 85 increased, 124 reduced and 20 closed positions. Its largest new stake was GFL Environmental: 313,947 shares worth $10M. The largest sale was Sarepta Therapeutics, an estimated $27.7M.
By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- TOBAM's largest Q2 2021 buy was GFL Environmental: 313,947 shares worth $10M.
- TOBAM added most to Eli Lilly in Q2 2021, an estimated $23M increase.
- TOBAM's biggest Q2 2021 reduction was Roku, cutting an estimated $20.6M.
- TOBAM fully exited Sarepta Therapeutics in Q2 2021, selling an estimated $27.7M.
- TOBAM's ten largest holdings make up 24% of its $2.5B portfolio in Q2 2021.
- TOBAM opened 26 new positions and closed 20 in Q2 2021.
- TOBAM's portfolio value rose 6.1% quarter-over-quarter to $2.5B.
Based on TOBAM's 13F filing for Q2 2021, filed 11 Aug 2021.